<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genomic Health, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genomic Health, Inc.

    Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      8071
    • NIN CODE
      ####
    • LEADERSHIP
      Kimberly Popovits
    • FOUNDED
      2000
    • EMPLOYEES
      501-1000
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company th...

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a ...

    Filing Type:    PU
    ACS Global, Inc.

    ACS Global, Inc.

    ACS Global, Inc. engages in the collection, processing, and long-term storage of s...

    ACS Global, Inc. engages in the collection, pro...

    Amount Raised:    $3,200,000
    Fundraising Status:    VT
    Filing Type:    PU
    Cerus Corporation

    Cerus Corporation

    Cerus Corporation is dedicated solely to safeguarding the world’s blood supply a...

    Cerus Corporation is dedicated solely to safegu...

    Filing Type:    PU
    Intellia Therapeutics, Inc.

    Intellia Therapeutics, Inc.

    Intellia Therapeutics is a leading genome editing company focused on developing cu...

    Intellia Therapeutics is a leading genome editi...

    Filing Type:    PU
    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow is here to change the way we think about artificial limbs. They...

    Unlimited Tomorrow is here to change the way we...

    Amount Raised:    $883,964.00
    Fundraising Status:    EC
    Filing Type:    CF
    NeoGenomics, Inc.

    NeoGenomics, Inc.

    NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory and phar...

    NeoGenomics, Inc. is a high-complexity CLIA-cer...

    Filing Type:    PU
    Co-Diagnostics, Inc.

    Co-Diagnostics, Inc.

    Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company with ...

    Co-Diagnostics, Inc., a Utah corporation, is a ...

    Filing Type:    PU
    Shionogi & Co. Ltd.

    Shionogi & Co. Ltd.

    Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, an...

    Shionogi & Co., Ltd. engages in the research, d...

    Filing Type:    PU
    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focused...

    SELLAS Life Sciences Group, Inc. is a late-stag...

    Filing Type:    PU
    Vascular Biogenics Ltd.

    Vascular Biogenics Ltd.

    VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharm...

    VBL Therapeutics is a publicly traded (NASDAQ: ...

    Filing Type:    PU
    Radius Health, Inc.

    Radius Health, Inc.

    Radius is a science-driven fully integrated biopharmaceutical company that is comm...

    Radius is a science-driven fully integrated bio...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.